ArticleCancers2020

Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients.

Eline Berghmans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.